Sofosbuvir Enrolling by Invitation Phase 3 Trials for Hepatitis C Viral Infection / Hepatitis C Virus (HCV) Infection Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03092375Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects